IFNG and graft versus host disease: Then, Ren et al. demonstrated that IFNγ combined with TNFα, IL-1α, or IL-1β activated iNOS in mouse MSCs, which resulted in NO increase and subsequent immunomodulation, as shown in a GVHD mouse model [99].